Generic competition is the most effective way to lower prescription drug prices, but the Medicare program designed to set the price of certain medicines may upend that market and stand in the way of more affordable medications. Consider Pomalyst, a cancer medication for multiple myeloma and for AIDS-related Kaposi sarcoma. It is one of the […]
Author Archives: MacKay Jimeson
MacKay Jimeson is the executive director of the Patient Access and Affordability Project at Patients Rising. He wrote this for InsideSources.com.
